Psychiatric pharmacogenomics
By: by David A. Mrazek.
Publisher: Oxford University Press
Published: 2010
Place of publication: Oxford; New York
Language: eng
ISBN-13: 9780195367294
Subjects: Psychotropic drugs; Pharmacogenomics; Biotransformation -- genetics; Psychotropic Drugs -- adverse effects; Mental Disorders -- drug therapy; Psychotropic Drugs -- pharmacokinetics
Notes: Includes bibliographical references and index.
Table of contents: title: The language of molecular genetics; title: The fourteen genes; title: The problem and the solution; title: The cytochrome P450 2D6 gene; title: The cytochrome P450 2C19 gene; title: The cytochrome P450 2C9 gene; title: The cytochrome P450 1A2 gene; title: The catechol-o-methyltransferase gene; title: The SLC6A2 norepinephrine transporter gene; title: The SLC6A3 dopamine transporter gene; title: The SLC6A4 serotonin transporter gene; title: The serotonin 1A receptor gene; title: The serotonin 2A receptor gene; title: The serotonin 2C receptor gene; title: The dopamine D2 receptor gene; title: The dopamine D3 receptor gene; title: The dopamine D4 receptor gene; title: The clinical utility of psychiatric pharmacogenomic testing; title: Ethical issues to consider when using pharmacogenomic testing in psychiatric practice; title: Future development of psychiatric pharmacogenomic testing.